Comparison of clinical outcomes using activated partial thromboplastin time versus antifactor-Xa for monitoring therapeutic unfractionated heparin: A systematic review and meta-analysis
Rebecca Swayngim, Candice Preslaski, Clay Cothren Burlew, Jacob Beyer
Topics & Concepts
MedicinePartial thromboplastin timeMeta-analysisInternal medicineHeparinRelative riskIntensive care medicineConfidence intervalCoagulationHeparin-Induced Thrombocytopenia and ThrombosisVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and Outcomes